nodes	percent_of_prediction	percent_of_DWPC	metapath
Alprenolol—CYP2D6—Loratadine—atopic dermatitis	0.2	0.426	CbGbCtD
Alprenolol—CYP2D6—Diphenhydramine—atopic dermatitis	0.2	0.426	CbGbCtD
Alprenolol—CYP2D6—Dexamethasone—atopic dermatitis	0.069	0.147	CbGbCtD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00235	0.00441	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.0023	0.00433	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.0023	0.00432	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.0023	0.00432	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00225	0.00423	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00224	0.00422	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00224	0.00422	CbGpPWpGaD
Alprenolol—HTR1A—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.00224	0.00421	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.0022	0.00414	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—CCL11—atopic dermatitis	0.00213	0.004	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—FCER2—atopic dermatitis	0.0021	0.00394	CbGpPWpGaD
Alprenolol—ADRB3—GPCR ligand binding—CCL5—atopic dermatitis	0.00205	0.00386	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—CCR3—atopic dermatitis	0.002	0.00377	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—CCR3—atopic dermatitis	0.00196	0.00369	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CCL22—atopic dermatitis	0.00196	0.00368	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CCL22—atopic dermatitis	0.00195	0.00367	CbGpPWpGaD
Alprenolol—HTR1A—G alpha (i) signalling events—CCL5—atopic dermatitis	0.00193	0.00362	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—CCL27—atopic dermatitis	0.00192	0.00362	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—CCR3—atopic dermatitis	0.00192	0.00361	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CCL22—atopic dermatitis	0.00192	0.0036	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—CCR3—atopic dermatitis	0.00191	0.00359	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—CCL27—atopic dermatitis	0.00188	0.00354	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CCL22—atopic dermatitis	0.00187	0.00352	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.00186	0.0035	CbGpPWpGaD
Alprenolol—ADRB3—GPCR ligand binding—CCR5—atopic dermatitis	0.00185	0.00348	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—CCL27—atopic dermatitis	0.00184	0.00346	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.00182	0.00342	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—NPS—atopic dermatitis	0.00179	0.00336	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—TAC1—atopic dermatitis	0.00179	0.00336	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.00178	0.00335	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—CXCR3—atopic dermatitis	0.00175	0.0033	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—TAC1—atopic dermatitis	0.00175	0.00329	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—NPS—atopic dermatitis	0.00175	0.00329	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CCL27—atopic dermatitis	0.00175	0.00328	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CCL27—atopic dermatitis	0.00174	0.00327	CbGpPWpGaD
Alprenolol—HTR1A—G alpha (i) signalling events—CCR5—atopic dermatitis	0.00174	0.00326	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—CCR3—atopic dermatitis	0.00173	0.00326	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—CXCR3—atopic dermatitis	0.00171	0.00322	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—TAC1—atopic dermatitis	0.00171	0.00321	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—NPS—atopic dermatitis	0.00171	0.00321	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CCL27—atopic dermatitis	0.00171	0.00321	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—TAC1—atopic dermatitis	0.0017	0.0032	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—NPS—atopic dermatitis	0.0017	0.0032	CbGpPWpGaD
Alprenolol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.00168	0.00317	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—CXCR3—atopic dermatitis	0.00168	0.00315	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CCL27—atopic dermatitis	0.00167	0.00314	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—CXCR3—atopic dermatitis	0.00167	0.00314	CbGpPWpGaD
Alprenolol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.00165	0.0031	CbGpPWpGaD
Alprenolol—HTR1A—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.00161	0.00303	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.0016	0.00301	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—IL5—atopic dermatitis	0.00158	0.00297	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.00157	0.00295	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CCL17—atopic dermatitis	0.00157	0.00294	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CCL17—atopic dermatitis	0.00156	0.00293	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—NPS—atopic dermatitis	0.00155	0.00291	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—TAC1—atopic dermatitis	0.00155	0.00291	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CCL17—atopic dermatitis	0.00153	0.00288	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.00153	0.00288	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—CXCR3—atopic dermatitis	0.00152	0.00285	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CCL17—atopic dermatitis	0.0015	0.00282	CbGpPWpGaD
Alprenolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.00147	0.00276	CbGpPWpGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	0.00146	0.00274	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.00144	0.00271	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—IL5—atopic dermatitis	0.00144	0.0027	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—CXCL10—atopic dermatitis	0.00142	0.00266	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.00141	0.00265	CbGpPWpGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	0.0014	0.00263	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—KIF3A—atopic dermatitis	0.00139	0.00261	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—CXCL10—atopic dermatitis	0.00139	0.00261	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.00138	0.00259	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—CXCL10—atopic dermatitis	0.00135	0.00255	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—CXCL10—atopic dermatitis	0.00135	0.00254	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CCL11—atopic dermatitis	0.00126	0.00237	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CCL11—atopic dermatitis	0.00126	0.00236	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CMA1—atopic dermatitis	0.00126	0.00236	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—FCER2—atopic dermatitis	0.00124	0.00234	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CCL11—atopic dermatitis	0.00123	0.00232	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—CXCL10—atopic dermatitis	0.00122	0.0023	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—CCL5—atopic dermatitis	0.00122	0.00229	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—FCER2—atopic dermatitis	0.00122	0.00229	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CCL11—atopic dermatitis	0.00121	0.00227	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—CCL5—atopic dermatitis	0.00119	0.00224	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—FCER2—atopic dermatitis	0.00119	0.00224	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—STAT6—atopic dermatitis	0.00118	0.00222	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—CCL5—atopic dermatitis	0.00117	0.00219	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—CCL5—atopic dermatitis	0.00116	0.00218	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CCL22—atopic dermatitis	0.00116	0.00218	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—CCR3—atopic dermatitis	0.00113	0.00213	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CCL22—atopic dermatitis	0.00113	0.00213	CbGpPWpGaD
Alprenolol—ADRB3—GPCR ligand binding—CXCL8—atopic dermatitis	0.00112	0.0021	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—CCR3—atopic dermatitis	0.00111	0.00208	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CCL22—atopic dermatitis	0.00111	0.00208	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—CCR5—atopic dermatitis	0.0011	0.00207	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—CCR3—atopic dermatitis	0.00108	0.00204	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—CCR5—atopic dermatitis	0.00107	0.00202	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—CCL5—atopic dermatitis	0.00105	0.00198	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—CCR5—atopic dermatitis	0.00105	0.00198	CbGpPWpGaD
Alprenolol—HTR1A—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.00105	0.00197	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—CCR5—atopic dermatitis	0.00105	0.00197	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CCL27—atopic dermatitis	0.00103	0.00194	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CCR3—atopic dermatitis	0.00103	0.00193	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CCR3—atopic dermatitis	0.00102	0.00193	CbGpPWpGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—TNF—atopic dermatitis	0.00101	0.00191	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—NPS—atopic dermatitis	0.00101	0.0019	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—TAC1—atopic dermatitis	0.00101	0.0019	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CCL27—atopic dermatitis	0.00101	0.0019	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CCR3—atopic dermatitis	0.00101	0.00189	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.00099	0.00186	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—TAC1—atopic dermatitis	0.000988	0.00186	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—NPS—atopic dermatitis	0.000988	0.00186	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CCL27—atopic dermatitis	0.000986	0.00185	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CCR3—atopic dermatitis	0.000984	0.00185	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000969	0.00182	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—TAC1—atopic dermatitis	0.000966	0.00182	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—NPS—atopic dermatitis	0.000966	0.00182	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—CCR5—atopic dermatitis	0.00095	0.00179	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000947	0.00178	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—IL5—atopic dermatitis	0.000939	0.00177	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CCL17—atopic dermatitis	0.000925	0.00174	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—IL5—atopic dermatitis	0.000918	0.00173	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—TAC1—atopic dermatitis	0.000917	0.00172	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—NPS—atopic dermatitis	0.000917	0.00172	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—TAC1—atopic dermatitis	0.000913	0.00172	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—NPS—atopic dermatitis	0.000913	0.00172	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CCL17—atopic dermatitis	0.000905	0.0017	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CXCR3—atopic dermatitis	0.000899	0.00169	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—IL5—atopic dermatitis	0.000898	0.00169	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—NPS—atopic dermatitis	0.000897	0.00169	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—TAC1—atopic dermatitis	0.000897	0.00169	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CXCR3—atopic dermatitis	0.000895	0.00168	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CCL17—atopic dermatitis	0.000885	0.00166	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CXCR3—atopic dermatitis	0.00088	0.00165	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—TAC1—atopic dermatitis	0.000877	0.00165	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—NPS—atopic dermatitis	0.000877	0.00165	CbGpPWpGaD
Alprenolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000872	0.00164	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CXCR3—atopic dermatitis	0.00086	0.00162	CbGpPWpGaD
Alprenolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000853	0.0016	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—IL5—atopic dermatitis	0.000853	0.0016	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—IL5—atopic dermatitis	0.000849	0.0016	CbGpPWpGaD
Alprenolol—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000834	0.00157	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—IL5—atopic dermatitis	0.000834	0.00157	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—KIF3A—atopic dermatitis	0.000824	0.00155	CbGpPWpGaD
Alprenolol—HTR1A—SIDS Susceptibility Pathways—IL6—atopic dermatitis	0.000818	0.00154	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—IL5—atopic dermatitis	0.000815	0.00153	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—KIF3A—atopic dermatitis	0.000806	0.00152	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—CXCL10—atopic dermatitis	0.0008	0.00151	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—KIF3A—atopic dermatitis	0.000789	0.00148	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000783	0.00147	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000766	0.00144	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CCL11—atopic dermatitis	0.000746	0.0014	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CMA1—atopic dermatitis	0.000746	0.0014	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CMA1—atopic dermatitis	0.000729	0.00137	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CCL11—atopic dermatitis	0.000729	0.00137	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CXCL10—atopic dermatitis	0.000727	0.00137	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CXCL10—atopic dermatitis	0.000723	0.00136	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CCL11—atopic dermatitis	0.000713	0.00134	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CMA1—atopic dermatitis	0.000713	0.00134	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CXCL10—atopic dermatitis	0.000711	0.00134	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—STAT6—atopic dermatitis	0.000701	0.00132	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CXCL10—atopic dermatitis	0.000695	0.00131	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—CCL5—atopic dermatitis	0.000689	0.0013	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—STAT6—atopic dermatitis	0.000686	0.00129	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—CCL5—atopic dermatitis	0.000674	0.00127	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—STAT6—atopic dermatitis	0.000671	0.00126	CbGpPWpGaD
Alprenolol—ADRB1—GPCR ligand binding—CXCL8—atopic dermatitis	0.000664	0.00125	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—CCL5—atopic dermatitis	0.000659	0.00124	CbGpPWpGaD
Alprenolol—ADRB2—GPCR ligand binding—CXCL8—atopic dermatitis	0.00065	0.00122	CbGpPWpGaD
Alprenolol—HTR1A—GPCR ligand binding—CXCL8—atopic dermatitis	0.000635	0.00119	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000632	0.00119	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CCL5—atopic dermatitis	0.000626	0.00118	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CCL5—atopic dermatitis	0.000623	0.00117	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—CCR5—atopic dermatitis	0.000621	0.00117	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CCL5—atopic dermatitis	0.000612	0.00115	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CCR3—atopic dermatitis	0.000608	0.00114	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—CCR5—atopic dermatitis	0.000607	0.00114	CbGpPWpGaD
Alprenolol—ADRB3—GPCR downstream signaling—IL2—atopic dermatitis	0.000604	0.00114	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CCL5—atopic dermatitis	0.000599	0.00113	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CCR3—atopic dermatitis	0.000595	0.00112	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—CCR5—atopic dermatitis	0.000594	0.00112	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CCR3—atopic dermatitis	0.000581	0.00109	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—NGF—atopic dermatitis	0.000577	0.00108	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—GLB1—atopic dermatitis	0.000576	0.00108	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—CXCL8—atopic dermatitis	0.000574	0.00108	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CCR5—atopic dermatitis	0.000564	0.00106	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CCR5—atopic dermatitis	0.000561	0.00106	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—ADSL—atopic dermatitis	0.000553	0.00104	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CCR5—atopic dermatitis	0.000551	0.00104	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—IL2—atopic dermatitis	0.000549	0.00103	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NPS—atopic dermatitis	0.000542	0.00102	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—TAC1—atopic dermatitis	0.000542	0.00102	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CCR5—atopic dermatitis	0.000539	0.00101	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CXCR3—atopic dermatitis	0.000531	0.000999	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NPS—atopic dermatitis	0.00053	0.000997	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—TAC1—atopic dermatitis	0.00053	0.000997	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CXCR3—atopic dermatitis	0.00052	0.000977	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NPS—atopic dermatitis	0.000518	0.000974	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—TAC1—atopic dermatitis	0.000518	0.000974	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CXCR3—atopic dermatitis	0.000508	0.000956	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IL5—atopic dermatitis	0.000504	0.000947	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IL5—atopic dermatitis	0.000493	0.000926	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IL5—atopic dermatitis	0.000482	0.000906	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—NFKBIA—atopic dermatitis	0.000476	0.000895	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CXCL10—atopic dermatitis	0.000429	0.000808	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CXCL10—atopic dermatitis	0.00042	0.00079	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CXCL10—atopic dermatitis	0.000411	0.000772	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000375	0.000706	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CCL5—atopic dermatitis	0.00037	0.000695	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000367	0.00069	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CCL5—atopic dermatitis	0.000362	0.00068	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000359	0.000675	CbGpPWpGaD
Alprenolol—ADRB1—GPCR downstream signaling—IL2—atopic dermatitis	0.000359	0.000675	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CCL5—atopic dermatitis	0.000354	0.000665	CbGpPWpGaD
Alprenolol—ADRB2—GPCR downstream signaling—IL2—atopic dermatitis	0.000351	0.00066	CbGpPWpGaD
Alprenolol—HTR1A—GPCR downstream signaling—IL2—atopic dermatitis	0.000343	0.000645	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NGF—atopic dermatitis	0.000342	0.000644	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—CXCL8—atopic dermatitis	0.000341	0.000641	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—CXCL8—atopic dermatitis	0.000339	0.000638	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NGF—atopic dermatitis	0.000335	0.00063	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—CXCL8—atopic dermatitis	0.000333	0.000627	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CCR5—atopic dermatitis	0.000333	0.000626	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NGF—atopic dermatitis	0.000327	0.000616	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—CXCL8—atopic dermatitis	0.000326	0.000613	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CCR5—atopic dermatitis	0.000326	0.000613	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—IL2—atopic dermatitis	0.000326	0.000613	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—IL2—atopic dermatitis	0.000324	0.00061	CbGpPWpGaD
Alprenolol—ADRB3—Signaling by GPCR—IL6—atopic dermatitis	0.000323	0.000607	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—IL2—atopic dermatitis	0.000319	0.000599	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CCR5—atopic dermatitis	0.000319	0.000599	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—IL2—atopic dermatitis	0.000312	0.000586	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—MAPK8—atopic dermatitis	0.000298	0.000561	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—NFKBIA—atopic dermatitis	0.000282	0.000531	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—NFKBIA—atopic dermatitis	0.000276	0.000519	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—NFKBIA—atopic dermatitis	0.00027	0.000508	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—CXCL8—atopic dermatitis	0.000201	0.000379	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—CXCL8—atopic dermatitis	0.000197	0.00037	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—CXCL8—atopic dermatitis	0.000193	0.000362	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IL2—atopic dermatitis	0.000192	0.000362	CbGpPWpGaD
Alprenolol—ADRB1—Signaling by GPCR—IL6—atopic dermatitis	0.000191	0.00036	CbGpPWpGaD
Alprenolol—ADRB3—Signaling Pathways—IL6—atopic dermatitis	0.000191	0.000358	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IL2—atopic dermatitis	0.000188	0.000354	CbGpPWpGaD
Alprenolol—ADRB2—Signaling by GPCR—IL6—atopic dermatitis	0.000187	0.000352	CbGpPWpGaD
Alprenolol—CYP2D6—Metabolism—PPARA—atopic dermatitis	0.000187	0.000352	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IL2—atopic dermatitis	0.000184	0.000346	CbGpPWpGaD
Alprenolol—HTR1A—Signaling by GPCR—IL6—atopic dermatitis	0.000183	0.000344	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—MAPK8—atopic dermatitis	0.000177	0.000333	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—MAPK8—atopic dermatitis	0.000173	0.000326	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—MAPK8—atopic dermatitis	0.000169	0.000319	CbGpPWpGaD
Alprenolol—ADRB1—Signaling Pathways—IL6—atopic dermatitis	0.000113	0.000213	CbGpPWpGaD
Alprenolol—ADRB2—Signaling Pathways—IL6—atopic dermatitis	0.000111	0.000208	CbGpPWpGaD
Alprenolol—HTR1A—Signaling Pathways—IL6—atopic dermatitis	0.000108	0.000203	CbGpPWpGaD
